Acrobat Genomics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 7

Acrobat Genomics General Information

Description

Developer of a drug discovery platform designed to offer precise gene editing therapeutics. The company utilizes high-throughput CRISPR gene editing precision technology to create a pipeline of new therapies for various diseases, enabling medical professionals to access suitable drugs to improve the treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 930 Brittan Avenue
  • San Carlos, CA 94070
  • United States
+1 (415)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • 930 Brittan Avenue
  • San Carlos, CA 94070
  • United States
+1 (415)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acrobat Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 01-Apr-2024 Completed Startup
3. Accelerator/Incubator 01-Jan-2024 Completed Startup
2. Early Stage VC 12-Dec-2022 Completed Startup
1. Accelerator/Incubator 14-Sep-2022 Completed Startup
To view Acrobat Genomics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Acrobat Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acrobat Genomics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
California Life Sciences Accelerator/Incubator
First In Ventures Venture Capital Minority
Forcefield Venture Venture Capital Minority
R42 Group Venture Capital Minority
Stanford University University Minority
You’re viewing 5 of 7 investors. Get the full list »

Acrobat Genomics FAQs

  • When was Acrobat Genomics founded?

    Acrobat Genomics was founded in 2022.

  • Where is Acrobat Genomics headquartered?

    Acrobat Genomics is headquartered in San Carlos, CA.

  • What is the size of Acrobat Genomics?

    Acrobat Genomics has 6 total employees.

  • What industry is Acrobat Genomics in?

    Acrobat Genomics’s primary industry is Discovery Tools (Healthcare).

  • Is Acrobat Genomics a private or public company?

    Acrobat Genomics is a Private company.

  • What is Acrobat Genomics’s current revenue?

    The current revenue for Acrobat Genomics is .

  • Who are Acrobat Genomics’s investors?

    California Life Sciences, First In Ventures, Forcefield Venture, R42 Group, and Stanford University are 5 of 7 investors who have invested in Acrobat Genomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »